DLA Troop Support Medical License of Curvo-BroadJump.
DEPT OF DEFENSE
This opportunity closed July 20, 2026. 5 similar opportunities are open right now.
Similar opportunities open now
- IQVIA PHARMACEUTICAL/SURGICAL/MEDICAL DEVICE & SUPPLY SALES DATA FOR DEFENSE LOGISTICS AGENCY (DLA) TROOP SUPPORT, MEDICAL DIRECTORATESame funderOpenDEPT OF DEFENSECloses today
- DLA Medical Equipment Electronic CATalog (ECAT) Generation V ProgramSame funderOpenDEPT OF DEFENSECloses Dec 2026
- Subscription Provided via CD-ROM (Military Electronics Briefing, World Missiles & UAW Briefing, World Military & Civil Aircraft Briefing, World Space Systems Briefing)Same funderOpenDEPT OF DEFENSENo deadline listed
- Biomedical Subscription ServicesSame funderOpenDEPT OF DEFENSENo deadline listed
- Procurement of Computer Software for Laboratory TestingOpenVETERANS AFFAIRS, DEPARTMENT OFNo deadline listed
About this archived opportunity
The Defense Logistics Agency - Troop (DLA-TS) Support Medical Directorate has a requirement to obtain a subscription agreement for Curvo- BroadJump Data License and PharmaChecker license. This license is required to provide pharmaceutical databases that include descriptive drug information and pricing transparency in support of pharmacy procurement and analysis, which promises to lower healthcare costs and improve patient care. The database is required to provide critical classification data for DLA Troop Support on a weekly basis to enable cross references of products or equivalent products such as therapeutically equivalent products, pharmaceutically equivalent products, etc. Curvo-BroadJump product information is also required in numerous DLA Troop Support Medical system applications as well as in downstream service customer systems and catalogs.
Historical details
- Status
- Closed
- Deadline
- July 20, 2026
- First captured
- July 14, 2026
- Publisher reference
- 52416569838c4159ab2a5c78640e1f02
Free. One email, sent if this program reopens or Funding Landscape first discovers a close match that is currently open. We watch for 12 months, then stop. No list.